Clinical trial
A National Registry on Chinese Patients With Lymphangioleiomyomatosis
NCT03193892
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedA National Registry on Chinese Patients With Lymphangioleiomyomatosis
Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Pulmonary Functionunresolved
Interventions
Sponsors & collaborators
Peking Union Medical College Hospitallead sponsor
Shanghai Zhongshan Hospitalcollaborator
Guangzhou Institute of Respiratory Diseasecollaborator
Central South Universitycollaborator
Anhui Provincial Hospitalcollaborator
Xiangya Hospital of Central South Universitycollaborator
Wuxi People's Hospitalcollaborator
West China Hospitalcollaborator
Fujian Provincial Hospitalcollaborator
Wuhan TongJi Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03193892 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.